News
In vitro liver cell models to study drug-induced liver injury
Monday, 11 April 2016 22:45A researcher group headed by Dr. Georg Damm from the Clinic of General, Visceral and Transplantation Surgery, Charité Berlin developes immunocompetent liver cell models that make it possible to examine fatty acid- and drug-induced liver damages.
USA: On the way to Human-on-a-chip
Wednesday, 06 April 2016 08:37The American company Emulate Inc., headquartered in Boston will receive a financial injection of 28 million dollars to implement their organ-on-a-chip technology in ready-to-use systems for industrial application. Aim is, inter alia, an improved drug development.
New: Course events at CAAT Academy
Wednesday, 30 March 2016 10:23With the aim to promote the implementation of new approaches as a replacement to animal experiments, the Center for Alternatives to Animal Testing (CAAT) at Johns Hopkins University in Baltimore and CAAT-Europe at the University of Constance have launched a training course program.
The sessions of the practical, one and two-day training courses are led by specialists in the respective areas. The events take place in different European countries.
Nominations for this year’s Lush Prize open on 25 April 2016
Tuesday, 29 March 2016 08:16Once again, £250,000 prize money, provided by Lush Cosmetics, will be shared by the winners to support the ending of animal experiments in research, industry and training.
MOSAIC: New platform for signal transduction analyses in cells
Thursday, 17 March 2016 16:03Scientists from the Institute for Biological Interfaces at Karlsruhe Institute of Technology (KIT), headed by Prof. Christoph Niemeyer have developed a platform that can be used to study fundamental aspects of early stages of signal transduction in living cells.
Adult stem cells in high throughput
Tuesday, 15 March 2016 10:46A European research team is in the process to produce mesenchymal stem cells by robots in mass on the assembly line. Therefore it should be possible for the treatment of arthritis, various cancer or organ diseases to deliver therapeutic stem cells quickly, cleanly and in sufficient quantities.
Zika virus (ZIKV) infects human embryonic cortical neural progenitor cells (hNPCs)
Wednesday, 09 March 2016 15:22A group of american scientists from Florida State University, from Johns Hopkins University and from Emory University School of medicine were able to observe that the Zika virus directly infects human cortical neural progenitor cells with high efficiency.
EUSAAT Congress to animal testing alternatives 2016: Abstracts can be submitted
Monday, 29 February 2016 10:22From 24th to 27th of August, the Congress on Alternatives to Animal Testing takes place again in Linz (Austria). It will be organized by the European Society for Alternatives to Animal Testing (EUSAAT).
ECHA gives out registration data to support development of non-test methods
Thursday, 18 February 2016 21:56The European Chemical Industry Council (Cefic) has been given access to certain data from ECHA's chemicals database to develop a new tool for predicting toxicity of chemicals.
ECVAM: Alternatives to animal testing - EU Public survey launched
Wednesday, 03 February 2016 12:19Following the European Commission's Communication published in response to the European Citizens' Initiative "Stop Vivisection", the JRC's Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) is conducting a public survey to solicit input from individuals and organisations to identify all types of knowledge sources that might be relevant for Replacing, Reducing or Refining (the '3Rs') the use of animals for scientific purposes.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.